default author photo

Anish Thomas

National Institutes of Health - Developmental Therapeutics Branch

Building 37, Room 5068A

Bethesda, MD 20892-4264

United States

  • National Institutes of Health - Developmental Therapeutics Branch

SCHOLARLY PAPERS

6

DOWNLOADS

286

TOTAL CITATIONS

3

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

APOBEC Mutagenesis and Copy Number Alterations are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors

Number of pages: 93 Posted: 17 Jul 2018
Nitin Roper, Shaojian Gao, Tapan K. Maity, A. Rouf Banday, Xu Zhang, Abhilash Venugopalan, Constance M. Cultraro, Rajesh Patidar, Sivasish Sindiri, Alexandr Goncearenco, Anna R. Panchenko, Romi Biswas, Anish Thomas, Arun Rajan, Corey A. Carter, David Kleiner, Stephen Hewitt, Javed Khan, Ludmila Prokunina-Olsson and Udayan Guha
Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Laboratory of Translational Genomics, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Genetics Branch, Government of the United States of America - Genetics Branch, Government of the United States of America - National Center for Biotechnology Information, Government of the United States of America - National Center for Biotechnology Information, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Walter Reed National Military Medical Center, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, National Institute of Health (NIH) - Genetics Branch, Government of the United States of America - Laboratory of Translational Genomics and Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch
Downloads 118 (604,538)
Citation 1

Abstract:

Loading...

2.

Replication Stress Defines Distinct Molecular Subtypes Across Cancers

Number of pages: 98 Posted: 22 Jul 2021
Nobuyuki Takahashi, Sehyun Kim, Vinodh Rajapakse, Christopher Schultz, Yang Zhang, Christophe E. Redon, Haiqing Fu, Lorinc Pongor, Suresh Kumar, Yves Pommier, Mirit I. Aladjem and Anish Thomas
National Cancer Institute - Developmental Therapeutics Branch, National Cancer Institute - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - Developmental Therapeutics Branch, National Cancer Institute - Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, National Institutes of Health - Developmental Therapeutics Branch and National Institutes of Health - Developmental Therapeutics Branch
Downloads 47 (1,097,529)
Citation 1

Abstract:

Loading...

3.

SCLC_CellMiner: Integrated Genomics and Therapeutics Predictors of Small Cell Lung Cancer Cell Lines Based on Their Genomic Signatures

Number of pages: 52 Posted: 12 Mar 2020
Camille Tlemsani, Lorinc Sandor Pongor, Luc Girard, Sudhir Varma, Augustin Luna, Vinodh Rajapakse, Robin Sebastian, Kurt Kohn, Julia Krushkal, Mirit I. Aladjem, Beverly A. Teicher, Paul S. Meltzer, William Reinhold, John Minna, Anish Thomas and Yves Pommier
National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, University of Texas at Dallas - Southwestern Medical Center, National Institutes of Health - Developmental Therapeutics Branch, Dana Farber Cancer Institute - cBio Center, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health (NIH), National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health (NIH), National Cancer Institute - Center for Cancer Research, National Institutes of Health - Developmental Therapeutics Branch, University of Texas at Dallas - Simmons Comprehensive Cancer Center, National Institutes of Health - Developmental Therapeutics Branch and Center for Cancer Research, National Cancer Institute, NIH, Bethesda
Downloads 42 (1,157,785)
Citation 1

Abstract:

Loading...

4.

CellMinerCDB for Integrative Genomics and Pharmacogenomics Analyses of Cancer Cell Lines

Number of pages: 31 Posted: 08 Jun 2018
Vinodh Rajapakse, Augustin Luna, Mihoko Yamade, Lisa Loman, Sudhir Varma, Margot Sunshine, Francesco Iorio, Fabricio G. Sousa, Fathi Elloumi, Mirit I. Aladjem, Anish Thomas, Chris Sander, Kurt Kohn, Cyril H. Benes, Mathew Garnett, William Reinhold and Yves Pommier
National Institutes of Health - Developmental Therapeutics Branch, Dana Farber Cancer Institute - cBio Center, Hamamatsu University - First Department of Medicine, Government of the United States of America - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - Developmental Therapeutics Branch, Wellcome Genome Campus - Wellcome Sanger Institute, Universidade Federal de Mato Grosso - Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica, Government of the United States of America - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, Dana Farber Cancer Institute - cBio Center, National Institutes of Health - Developmental Therapeutics Branch, Harvard University - Cancer Center, Wellcome Genome Campus - Wellcome Trust Sanger Institute, National Institutes of Health - Developmental Therapeutics Branch and Center for Cancer Research, National Cancer Institute, NIH, Bethesda
Downloads 42 (1,157,785)

Abstract:

Loading...

5.

ATR Inhibition Augments the Efficacy of Lurbinectedin in Small Cell Lung Cancer

Number of pages: 45 Posted: 13 Apr 2022
Christopher Schultz, Yang Zhang, Rajaa Elmeskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Thomas Ried, Mirit I. Aladjem, Frank T. Zenke, Zoe Weaver, Yves Pommier and Anish Thomas
National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - National Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, affiliation not provided to SSRN, Government of the United States of America - Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, National Institutes of Health - Developmental Therapeutics Branch, affiliation not provided to SSRN, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute and National Institutes of Health - Developmental Therapeutics Branch
Downloads 37 (1,222,651)

Abstract:

Loading...

Small Cell Lung Cancer, Lung Cancer, SCLC, Translational, Pre-clinical, synergy, combination, Biomarkers, ATR inhibitor, lurbinectedin, DNA-damage, cell-cycle

6.

p53-Independent Epigenetic Treatment for Chemo-Refractory Small Cell Lung Cancer: Bio-Rationale and in vivo Proof-of-Principle

Posted: 14 Mar 2023
Sudipta Biswas, Kai Kang, Kwok Peng Ng, Tomas Radivoyevitch, Kurt Schalper, Hua Zhang, Daniel Lindner, Anish Thomas, David MacPherson, Brian Gastman, David Schrump, Kwok-Kin Wong, Vamsi Velcheti and Yogen Saunthararajah
Cleveland Clinic - Department of Translational Hematology & Oncology Research, Cleveland Clinic - Department of Translational Hematology & Oncology Research, Cleveland Clinic - Department of Translational Hematology & Oncology Research, Cleveland Clinic - Department of Quantitative Health Sciences, Yale University - Department of Pathology, New York University (NYU) - Thoracic Oncology Program, Cleveland Clinic - Department of Translational Hematology & Oncology Research, National Institutes of Health - Developmental Therapeutics Branch, Fred Hutchinson Cancer Research Center, Cleveland Clinic - Department of Plastic Surgery, Government of the United States of America - Thoracic Epigenetics Section, New York University (NYU) - Thoracic Oncology Program, New York University (NYU) - Thoracic Oncology Program and Cleveland Clinic - Department of Translational Hematology & Oncology Research

Abstract:

Loading...

small cell lung cancer, Immune checkpoint blockade, Pyrimidine metabolism, Decitabine, 5azacytidine, Tetrahydrouridine.